MoneyWorks4Me

Cadila Healthcare’s Biologics manufacturing facility gets EIR from USFDA

05 Oct 2018 Evaluate

Cadila Healthcare’s Biologics manufacturing facility (Zydus Biologics) located at Ahmedabad has received an Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) signifying the successful closure of the audit from August 14 to August 24, 2018, with zero 483 observations.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..